You are here

Article info

Article menu
Download PDFPDF
Clinical science
Adalimumab for non-infectious uveitis: is it cost-effective?

Authors

  1. Correspondence to Dr Inigo Bermejo, ScHARR, University of Sheffield, Sheffield S1 4DA, UK; inigo.bermejo{at}gmail.com
View Full Text

Citation

Bermejo I, Squires H, Poku EN, et al
Adalimumab for non-infectious uveitis: is it cost-effective?
British Journal of Ophthalmology 2019;103:1633-1638.

Publication history

  • Received June 27, 2018
  • Revised December 5, 2018
  • Accepted December 15, 2018
  • First published February 6, 2019.
Online issue publication 
October 23, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.